The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss after 72 weeks with respect to the percentage change in body weight and the proportion of participants achieving weight loss of 5% or greater.1 Select confirmatory secondary endpoints included the proportion of participants achieving 10%, 15%, 20% and 25% weight loss, with semaglutide 7.2 mg vs placebo (and for 20% and 25%, semaglutide 7.2 mg vs semaglutide 2.4 mg).1 For those taking Wegovy HD, 89% achieved 5% or greater body weight loss versus 38% taking placebo (from a baseline body weight of 248 lb.).1,2 About obesity Obesity is a serious, chronic, progressive, and complex disease that requires long-term management.3-5 One key misunderstanding is that this is a disease of just lack of willpower, when in fact there is underlying biology that may impede people with obesity from losing weight and keeping it off.3,5 Obesity is influenced by a variety of factors, including genetics, social determinants of health, and the environment.6,7 What is Wegovy
While rare, these can be signs of a localized sensitivity that your medical team should know about
At Perfect B in Doral, we assess each patient individually and create a treatment sequence timed to their weight loss progress
But you've definitely eat a lot less and I think as long as you're a lot more mindful about what you're eating, don't go eat a bunch of cheese unless you have to
How PT-141 Timing Compares to Other Compounds Context is helpful
.jpg)
